postoperative aspiration pneumonia among adults using glp-1 receptor agonists The expanding role of agonists: a narrative review of current evidence and future directions The expanding role of GLP-1

Rita Kapoor Explain the Timeline for Appetite Suppression and Weight Loss.

not using GLP-1 receptor agonists had significantly lower relative risks for mortality and respiratory failure, according to a presentation at the CHEST Annual Meeting.In a retrospective study, Saud Alawad, MBBS, third-year internal medicine resident at West Virginia University, and colleagues analyzed adults with a group 1 PAH

Microdosing GLP-1 for Hashimoto's: explore the evidence, potential benefits, safety concerns, and NHS guidance on using GLP-1 receptor agonists for autoimmune thyroid disease and metabolic symptoms.

Amgens MariTide leads the GLP-1 obesity therapy market in 2025 with innovative design, Phase-3 trials, and strong potential for effective weight loss.

The primary outcome was change in HbA1c from baseline

Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D)